NovaDigm Therapeutics, Inc.   Report issue

For profit Phase 1 Phase 2
Founded: Grand Forks ND United States (2005)

Organization Overview

First Clinical Trial
2011
NCT01273922
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

NovaDigm Therapeutics, Inc.